{"We": [0, 117], "have": [1], "previously": [2], "provided": [3], "the": [4, 15, 28, 37], "first": [5], "genetic": [6], "evidence": [7], "that": [8, 65, 95, 120, 143], "angiotensin": [9], "converting": [10], "enzyme": [11], "2": [12], "(ACE2)": [13], "is": [14, 79], "critical": [16], "receptor": [17, 56], "for": [18, 36, 57], "severe": [19, 38], "acute": [20], "respiratory": [21], "syndrome": [22], "coronavirus": [23], "(SARS-CoV),": [24], "and": [25, 41, 60, 130], "ACE2": [26, 47, 86], "protects": [27], "lung": [29, 39], "from": [30, 102], "injury,": [31], "providing": [32], "a": [33, 54, 106], "molecular": [34], "explanation": [35], "failure": [40], "death": [42], "due": [43], "to": [44], "SARS-CoV": [45], "infections.": [46, 152], "has": [48, 62], "now": [49], "also": [50, 118], "been": [51, 63], "identified": [52], "as": [53], "key": [55], "SARS-CoV-2": [58, 100, 121, 151], "infections,": [59], "it": [61, 78], "proposed": [64], "inhibiting": [66], "this": [67], "interaction": [68], "might": [69], "be": [70, 136], "used": [71], "in": [72], "treating": [73], "patients": [74], "with": [75], "COVID-19.": [76], "However,": [77], "not": [80], "known": [81], "whether": [82], "human": [83, 126, 131], "recombinant": [84], "soluble": [85], "(hrsACE2)": [87], "blocks": [88], "growth": [89], "of": [90, 108, 150], "SARS-CoV-2.": [91], "Here,": [92], "we": [93], "show": [94, 119], "clinical": [96], "grade": [97], "hrsACE2": [98, 144], "reduced": [99], "recovery": [101], "Vero": [103], "cells": [104], "by": [105, 138], "factor": [107], "1,000-5,000.": [109], "An": [110], "equivalent": [111], "mouse": [112], "rsACE2": [113], "had": [114], "no": [115], "effect.": [116], "can": [122, 135, 145], "directly": [123], "infect": [124], "engineered": [125], "blood": [127], "vessel": [128], "organoids": [129], "kidney": [132], "organoids,": [133], "which": [134], "inhibited": [137], "hrsACE2.": [139], "These": [140], "data": [141], "demonstrate": [142], "significantly": [146], "block": [147], "early": [148], "stages": [149]}